Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
3.210
-0.230 (-6.69%)
At close: Aug 10, 2026, 4:00 PM EDT
3.270
+0.060 (1.87%)
After-hours: Aug 10, 2026, 8:00 PM EDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $7.26 million as of August 10, 2026. Its market cap has decreased by -43.02% in one year.
Market Cap
7.26M
Enterprise Value
-1.74M
1-Year Change
-43.02%
Ranking
Category
Stock Price
$3.21
ChartMarket Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from $18.49M to $7.26M, a decrease of -60.73%. That is a compound annual growth rate of -5.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 7.57M | -69.27% |
| Dec 31, 2025 | 24.64M | 58.34% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuron | 7.61M |
| CNS Pharmaceuticals | 7.50M |
| Kairos Pharma | 7.49M |
| MetaVia | 7.39M |
| AEON Biopharma | 7.30M |
| Processa Pharmaceuticals | 7.18M |
| Curis | 7.13M |
| Xenetic Biosciences | 7.08M |